The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease. On the back of mounting concerns about hydroxychloroquine's safety, global pharmaceutical major Sanofi (NASDAQ:SNY) has quit providing it to COVID-19 patients enrolled in its clinical trials for the drug. It has also put a temporary…
A box of Plaquenil, an anti-malaria drug hydroxychloroquine made by Sanofi, used for years to treat malaria and autoimmune disorders.Alain Pitton | NurPhoto | Getty ImagesFrench drugmaker Sanofi said Friday it is suspending recruitment of new patients for its clinical trials looking at anti-malaria drug hydroxychloroquine as a potential treatment for the coronavirus.The company is also…
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 6402cb11-43e1-4ad7-acc8-92cbdb81
You don't have permission to access "http://www.medpagetoday.com/nursing/nurses-station/118556" on this server. Reference #18.2a153b17.1763406143.e907b9a https://errors.edgesuite.net/18.2a153b17.1763406143.e907b9a
So you tried and failed to get the Bad Bunny edition Sambas. That's okay, you can still get an iconic version like these all-blacks. They really are the OG of Adidas footwear, appealing to all types from the athletes to the gamers and everybody in between. The perfect balance of leather and suede, these sneaks